|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
organism-gene
 |


|
   PR:P36940 tumor necrosis factor ligand superfamily member 6 (rat) |   rFASLG |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
organism-gene
 |


|
   PR:P41047 tumor necrosis factor ligand superfamily member 6 (mouse) |   mFASLG |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P41047-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) |   mFASLG/iso:FasL |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) |   mFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P41047-2 tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) |   mFASLG/iso:FasLS |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
organism-gene
 |


|
   PR:P48023 tumor necrosis factor ligand superfamily member 6 (human) |   hFASLG |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P48023-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (human) |   hFASLG/iso:FasL |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) |   hFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) |   hFASLG/iso:FasL/NGlyco:1 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) |   hFASLG/iso:FasL/Clv:soluble |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P48023-2 tumor necrosis factor ligand superfamily member 6 isoform h2 (human) |   hFASLG/iso:h2 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
sequence
 |


|
   PR:000000276 tumor necrosis factor ligand superfamily member 6 isoform FasL |   FASLG/iso:FasL |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
sequence
 |


|
   PR:000000278 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L |   FASLG/iso:FasL/var:F273L |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) |   hFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) |   mFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P41047-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) |   mFASLG/iso:FasL |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) |   mFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P48023-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (human) |   hFASLG/iso:FasL |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-sequence
 |


|
   PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) |   hFASLG/iso:FasL/var:F273L |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) |   hFASLG/iso:FasL/NGlyco:1 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) |   hFASLG/iso:FasL/Clv:soluble |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
modification
 |


|
   PR:000000432 tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form |   FASLG/iso:FasL/GlycoRes+ |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
modification
 |


|
   PR:000000546 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 |   FASLG/iso:FasL/NGlyco:1 |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |  |  |
organism-modification
 |


|
   PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) |   hFASLG/iso:FasL/NGlyco:1 |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
modification
 |


|
   PR:000000547 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form |   FASLG/iso:FasL/Clv:soluble |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) |   hFASLG/iso:FasL/Clv:soluble |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
sequence
 |


|
   PR:000000277 tumor necrosis factor ligand superfamily member 6 isoform FasLS |   FASLG/iso:FasLS |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
organism-sequence
 |


|
   PR:P41047-2 tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) |   mFASLG/iso:FasLS |
 Yes | 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |  |  |  |
modification
 |


|
   PR:000018277 tumor necrosis factor ligand superfamily member 6 proteolytic cleavage product |   FASLG/ClvPrd |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |
 |  |  |  |
modification
 |


|
   PR:000000547 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form |   FASLG/iso:FasL/Clv:soluble |

| 
|
|
|
 |
 |
|  |  |  |  |  |  |  |  |
 |  |
organism-modification
 |


|
   PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) |   hFASLG/iso:FasL/Clv:soluble |
 Yes | 
|
|
|